We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
(Reuters) - The U.S. government will consider opportunities to "bring greater transparency" for the Medicare drug price ...
Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...
Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...
Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...
The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...
The National Community Pharmacists Association (NPCA) is warning the feds that independent pharmacists are likely to face ...
President Donald Trump’s Medicare agency is seeking to bring more transparency to the US government’s drug price negotiation ...
The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback